author-photo

Gary Williams

Amgen

3

Papers

212

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects.

2015 Arthritis Research & Therapy
Show All
- Source
- Cite
- Save
Citations (16)
Letter to the EditorAnti-IL-17 Receptor Antibody AMG 827 Leads to Rapid Clinical Response in Subjects with Moderate to Severe Psoriasis: Results from a Phase I, Randomized, Placebo-Controlled Trial

2012 Journal of Investigative Dermatology
Show All
- Source
- Cite
- Save
Citations (84)
Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial.

2012 Journal of Investigative Dermatology
Show All
- Source
- Cite
- Save
Citations (112)